Transforming the Patient Clinical Lab Experience

by Bob Croce

For The Executive War College

Today’s healthcare consumers are demanding. They seek personalized care, convenient access to medical services, transparency in quality, and digital access to scheduling and clinical laboratory test results. 

The session is entitled, “Transforming the Patient’s Clinical Laboratory Experience: Novel Specimen Collection Solution Now Offered in Retail Pharmacies also Gives Labs a Unique Way to Add Value, Build Test Referrals.”

One trend being used by Babson is to bring specimen collection services closer to the growing number of customers who are moving from conventional patient service centers (PSCs) operated by clinical laboratories to alternative collection sites, particularly retail pharmacies. The second trend involves using technology to create a new collection method that includes the following: 

  • An environment that is friendlier to patients,
  • requires a much smaller quantities of samples, and,
  • can be used by labs to deliver accurate, reproducible results using most existing analyzers.


Eric Olson, Founder, Chairman, and Chief Operating Officer
at Babson Diagnostics, in Austin, TX.


As part of the session, clinical laboratory administrators and pathologists interested in keeping their respective labs’ strategies tuned to the realities of today’s healthcare marketplace will get insight into Babson’s market predictions and the diagnostic technologies it is developing. 

Attendees at this sessions will get further insight into the following: 

  • Consumers and Site of Service: Why moving specimen collection into retail pharmacies and similar settings better meets the expectations of today’s healthcare consumer while also benefitting clinical laboratories.

  • New Hybrid Collection and Test Model: Babson explains the hybrid model, which decentralizes specimen collection and centralizes the testing of the specimens.

  • New Specimen Collection Technology and Devices: How an alternative method for capillary blood specimen collection improves the patient experience and reduces the volume of sample required for many types of basic clinical laboratory tests. Equally important, why it will reduce the need for trained phlebotomists, including an overview of the clever designs of the different products under development to enable collection of smaller samples and their testing at the lab.

  • Centrifugation of Smaller Samples for Testing by the Clinical Lab: What is required for high volume laboratories to analyze the smaller quantities of capillary blood samples while maintaining accuracy.

  • Validation of Lab Assays Using Capillary Blood and Tested on High-Volume Analyzers: Babson’s team is conducting the validation studies necessary to demonstrate that capillary blood samples collected with the company’s technology consistently deliver accurate, reproducible results when tested by high-volume instruments.


That’s it for this week, more dispatches to come. Hope to see you and your “krewe” in New Orleans. 

Executive War College 2024, GS1 Meet and Greet.
Executive War College 2024 Break, Sandy richman
Executive War College 2024, Welcome Reception, AIMA
Executive War College 2024, Chris Myriad Genetics
Executive War College 2024, Large Group photo, ARUP.


Haven’t registered yet for EWC 2025?
Sign up by 3/21/25 and save $100 off full tuition.

Don’t miss our Day 3 workshops below on May 1

Workshop 1
Whole Genome Sequencing and Genetic Testing for Community Hospitals – Companion Diagnostics in Lab–Pharma Relationships

Workshop 2
Breaking Pathology’s Glass Slide Updated! Ways to Build Revenue with Digital Pathology, Whole Slide Images, AI Diagnostic Tools, and More

Workshop 3
Lean for Lab Leaders: Proven Ways to Swiftly Slash Costs While Boosting Productivity and Improving Staff Retention

Workshop 4
Assessing Recent Federal Laws, Regulations, and Court Cases: Vital Insights for Lab Executives and Their Attorneys

Workshop 5
What’s Changing in CLIA Compliance and Inspections: Essentials for Lab Quality Officers and CLIA Lab Directors